Association of phenotypic age and accelerated aging with severity and disability in patients with acute ischemic stroke - 03/11/24

Doi : 10.1016/j.jnha.2024.100405 
Yongkang Liu a, 1, Jiangchuan Wang a, 1, Zicheng Wei a, 1, Yu Wang a, Minghua Wu b, Jianhua Wang a, , Xiao Chen a, , Rong Chen c
a Department of Radiology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China 
b Encephalopathy Center, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China 
c Department of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine, 100 N Greene, Baltimore, MD 21201, United States 

Corresponding author.

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Abstract

Objective

Biological age may be more accurate than chronological age in determining chronic health outcomes. However, few studies have shown the association between biological age and acute ischemic stroke (AIS). In this study we showed the association between phenotypic age (PhenoAge) or accelerated aging and severity and disability in patients with AIS.

Design

Retrospective study.

Setting and subjects

936 patients with AIS during January 2019 to July 2021 and 512 patients during June 2022 to July 2023 for a validation.

Methods

Stroke severity was evaluated based on the National Institute of Health stroke scale (NIHSS) questionnaire scale. Disability was evaluated by modified Rankin Scale. PhenoAge was calculated based on chronological age and 9 clinical chemistry biomarkers. Logistic regression analyses were applied to estimate the relationship between PhenoAge and the severity and disability.

Results

PhenoAge (odds ratio [OR] = 1.03, 95% confidence interval [CI]: 1.0–1.04, for NIHSS ≥ 5; OR = 1.05, 95%CI: 1.03−1.07, for NIHSS ≥ 10) was independently associated with stroke severity. The probability of NIHSS ≥ 5 or NIHSS ≥ 10 was significantly increased in individuals with accelerated ageing versus individuals with no accelerated aging (age gap: OR = 1.79, 95%CI: 1.18−2.72; OR = 3.53, 95%CI: 1.60−7.77; phenotypically older vs. phenotypically younger: OR = 2.01, 95%CI: 1.21−3.35; OR = 3.69, 95%CI: 1.36−10.0). Similar trends was observed when accelerated aging was defined by residual discrepancies between PhenoAge and chronological age (OR = 1.02, 95%CI: 1.01−1.04, for NIHSS ≥ 5; OR = 1.05, 95%CI: 1.02−1.08, for NIHSS ≥ 10). The area under the curve of PhenoAge was higher than that of chronological age in identifying patients with NIHSS ≥ 5 (0.66, 95%CI:0.62−0.70 vs. 0.61, 95%CI: 0.58−0.65, p < 0.01) and NIHSS ≥ 10 (0.69, 95%CI:0.60−0.77 vs. 0.63, 95%CI: 0.55−0.72, p = 0.05). The probability of severe disability was significantly increased in individuals with accelerated aging versus individuals with no accelerated aging (age gap: OR = 2.87, 95%CI: 1.09−7.53; phenotypically older vs. phenotypically younger: 4.88 (1.20−19.88). Similar results were observed in the validation population.

Conclusion

PhenoAge or accelerated aging is associated with stroke severity and disability even after adjusting for chronological age.

El texto completo de este artículo está disponible en PDF.

Keywords : Acute ischemic stroke, Phenotypic age, Severity, NIHSS, Disability

Abbreviations : AIS, AUC, AST, CI, CRP, DBP, DWI, HDL-c, LDL-c, MCV, mRS, NIHSS, OR, ROC, SBP, TC, TG


Esquema


© 2024  The Authors. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 28 - N° 12

Artículo 100405- décembre 2024 Regresar al número
Artículo precedente Artículo precedente
  • Impact of diabetes on the association between serum urate levels and incident dementia: a cohort study in the UK biobank
  • Yuwei Peng, Lulu Pan, Qiuli Zhu, Ruilang Lin, Chen Huang, Yahang Liu, Yifang Huang, Guochen Li, Ye Yao, Yongfu Yu, Jianguo Tang
| Artículo siguiente Artículo siguiente
  • Breakfast energy intake and dietary quality and trajectories of cardiometabolic risk factors in older adults
  • Karla-Alejandra Pérez-Vega, Camille Lassale, María-Dolores Zomeño, Olga Castañer, Jordi Salas-Salvadó, F. Javier Basterra-Gortari, Dolores Corella, Ramón Estruch, Emilio Ros, Francisco J. Tinahones, Gemma Blanchart, Mireia Malcampo, Daniel Muñoz-Aguayo, Helmut Schröder, Montserrat Fitó, Álvaro Hernáez

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2024 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.